Biosynex SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 196.6 million compared to EUR 382.5 million a year ago. Net income was EUR 15.6 million compared to EUR 104 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 EUR | -10.16% | -15.14% | -66.11% |
05-28 | Biosynex: obtains CE markings under the new IVDR regulations | CF |
05-13 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
1st Jan change | Capi. | |
---|---|---|
-66.11% | 32.63M | |
-11.78% | 11.24B | |
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B | |
-19.12% | 1.57B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022